NorthRock Partners LLC Has $259,000 Holdings in Agilent Technologies, Inc. (NYSE:A)

NorthRock Partners LLC lessened its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 48.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,746 shares of the medical research company’s stock after selling 1,667 shares during the quarter. NorthRock Partners LLC’s holdings in Agilent Technologies were worth $259,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in A. Crewe Advisors LLC increased its holdings in Agilent Technologies by 114.8% during the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after purchasing an additional 101 shares in the last quarter. Livelsberger Financial Advisory bought a new position in Agilent Technologies during the 3rd quarter worth about $28,000. Ridgewood Investments LLC bought a new position in Agilent Technologies during the 2nd quarter worth about $29,000. Fortitude Family Office LLC increased its holdings in Agilent Technologies by 68.3% during the 3rd quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock worth $35,000 after purchasing an additional 95 shares in the last quarter. Finally, Ashton Thomas Private Wealth LLC bought a new position in Agilent Technologies during the 2nd quarter worth about $39,000. Institutional investors and hedge funds own 87.42% of the company’s stock.

Analyst Ratings Changes

A number of research firms have issued reports on A. Evercore ISI increased their target price on Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. TD Cowen raised their price objective on Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Barclays raised their target price on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “underweight” rating in a research note on Tuesday, October 15th. Bank of America raised their target price on shares of Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. Finally, Wells Fargo & Company initiated coverage on shares of Agilent Technologies in a research note on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 target price for the company. One research analyst has rated the stock with a sell rating, five have given a hold rating and nine have given a buy rating to the company. According to MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and an average price target of $144.36.

Insider Activity at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total transaction of $283,910.00. Following the completion of the transaction, the chief executive officer now directly owns 24,118 shares in the company, valued at approximately $3,497,110. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, SVP Dominique Grau sold 9,990 shares of the company’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now directly owns 40,011 shares in the company, valued at approximately $5,801,595. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the sale, the chief executive officer now owns 24,118 shares of the company’s stock, valued at $3,497,110. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 11,995 shares of company stock valued at $1,739,510 over the last three months. 0.33% of the stock is owned by insiders.

Agilent Technologies Stock Down 1.9 %

NYSE A opened at $137.78 on Thursday. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. Agilent Technologies, Inc. has a 1-year low of $104.09 and a 1-year high of $155.35. The company has a 50 day moving average of $139.64 and a 200-day moving average of $138.18. The company has a market cap of $39.59 billion, a price-to-earnings ratio of 28.59, a PEG ratio of 6.02 and a beta of 1.07.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.06. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the previous year, the business earned $1.43 earnings per share. The firm’s quarterly revenue was down 5.6% on a year-over-year basis. On average, equities research analysts expect that Agilent Technologies, Inc. will post 5.24 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st were paid a $0.236 dividend. The ex-dividend date was Tuesday, October 1st. This represents a $0.94 dividend on an annualized basis and a yield of 0.69%. Agilent Technologies’s dividend payout ratio (DPR) is 19.50%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.